Patent · US Expired

Pyrimidine compound and medical use thereof

US7378423B2 · kind B2 · utility

30Cited by
0References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2005
Grant dateMay 27, 2008
Priority date
Expiry dateSep 13, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I]wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.